Related Experiment Videos
Rubella 1974 and its aftermath, congenital rubella syndrome
Abstract:
An epidemic of rubella reached its peak in the Atlantic provinces in 1974, subsiding in early 1975. With the exception of Quebec the remainder of Canada showed a reverse trend, with a large increase in the numbers of cases reported in the first 41/2 months of 1975. The Halifax virus laboratory reported 106 serologically proven cases of rubella in 1974, 44 of them in pregnant women. In the aftermath of the epidemic many infants were born with the congenital rubella syndrome (CRS). A study carried out from Sept. 1, 1974 through Apr. 30, 1975 showed an 80% correlation between clinical diagnosis and the presence of rubella-specific IgM antibodies in 35 of these infants. Of the 23 infants in whom the diagnosis of CRS was made by laboratory or clinical findings or both, laboratory criteria were met in 20 (87.0%), clinical criteria in 19 (82.6%) and both laboratory and clinical criteria in 16 (69.6%).
Insights
A 1974 rubella epidemic led to congenital rubella syndrome (CRS) cases. Laboratory tests confirmed rubella-specific IgM antibodies in 80% of infants, aiding diagnosis.
Area of Science:
- Virology
- Epidemiology
- Pediatrics
- Immunology
Background:
- A significant rubella epidemic occurred in Canada in 1974, particularly impacting the Atlantic provinces.
- The epidemic resulted in a notable number of infants born with congenital rubella syndrome (CRS).
- Diagnostic challenges existed for confirming CRS in newborns following the epidemic.
Purpose of the Study:
- To evaluate the correlation between clinical diagnosis and laboratory confirmation of rubella-specific IgM antibodies in infants suspected of having CRS.
- To assess the diagnostic accuracy of clinical versus laboratory criteria for congenital rubella syndrome.
Main Methods:
- A study was conducted between September 1, 1974, and April 30, 1975.
- Infants with suspected congenital rubella syndrome were assessed.
- Rubella-specific IgM antibody testing was performed, and clinical diagnoses were recorded.
Main Results:
- An 80% correlation was found between clinical diagnosis and the presence of rubella-specific IgM antibodies in 35 infants.
- Of 23 infants diagnosed with CRS, laboratory criteria confirmed the diagnosis in 87.0% (20 infants).
- Clinical criteria supported the CRS diagnosis in 82.6% (19 infants), while both criteria were met in 69.6% (16 infants).
Conclusions:
- Rubella-specific IgM antibody testing is a reliable method for diagnosing congenital rubella syndrome.
- Laboratory confirmation significantly aids in the accurate diagnosis of CRS, complementing clinical assessments.
- The study highlights the importance of serological testing in the aftermath of rubella outbreaks to identify affected infants.